Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation

Although the oral administration of Bifidobacterium longum (B. longum) relieves the signs of irritable bowel syndrome (IBS) in clinical settings, the mechanisms underlying its effects are unclear. In this study, we evaluated the precise effects of B. longum on IBS via regulation of Paneth cell funct...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gut Microbes
Main Authors: Zhou, Chunhua, Fang, Xue, Xu, Jiajia, Gao, Jun, Zhang, Ling, Zhao, Jiulong, Meng, Yuting, Zhou, Wei, Han, Xu, Bai, Yu, Li, Zhaoshen, Zou, Duowu
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524277/
https://ncbi.nlm.nih.gov/pubmed/32584650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19490976.2020.1782156
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados